Options Brief: Momenta Pharmaceuticals

Shares of Momenta Pharmaceuticals MNTA are higher on the session by 0.31%, trading at $19.44. Overall put volume is now running at 3.25x the daily average, with 1% of all puts traded being purchases on the offer. 2,050 contracts have traded on the session so far. Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans.